Risk factors determining central venous access device-associated deep vein thrombosis resolution in children: a retrospective study

被引:1
作者
Garcia-Boyano, Miguel [1 ]
Caballero-Caballero, Jose Manuel [1 ]
Garcia Fernandez de Villalta, Marta [1 ]
Gutierrez Alvarino, Mar [1 ]
Blanco Banares, Maria Jesus [1 ]
Climent Alcala, Francisco Jose [1 ]
机构
[1] La Paz Univ Hosp, Madrid, Spain
关键词
Venous thrombosis; Low-molecular-weight heparin; Children; Risk factors; Thrombus resolution; UNITED-STATES; ILL CHILDREN; THROMBOEMBOLISM; SCORE;
D O I
10.1007/s00431-021-03985-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The risk factors associated with the probability of central venous access device (CVAD)-associated deep vein thrombosis (DVT) resolution have been hardly evaluated in children. Current guidelines suggest anticoagulation for a maximum of 3 months in patients with provoked DVT if the provoking factor is resolved. To know if the thrombus will resolve after anticoagulant therapy will help to choose whether to initiate and/or continue this treatment or not. We did a retrospective study of 85 pediatric patients (45 girls, 40 boys) with CVAD-associated DVT to examine the risk factors associated with lack of thrombus resolution in the first 6 months after diagnosis. Sixty-two children had their thrombosis resolved after a median of 50 days (p25-p75 25-97) since diagnosis. In multivariate analysis, variables significantly associated with no resolution were total occlusion (OR 12.50, 95% CI 2.99-52.14, p=.001), location in upper extremity, head, and neck veins (OR 17.70, 95% CI 1.64-191.43, p=.018); collateral circulation in the first 45 days after diagnosis (OR 33.55, 95% CI 2.42-464.71, p=.009); and having between 0 and 3 prothrombotic risk factors at diagnosis (OR 6.20, 95% CI 1.21-31.75, p=.029). Conclusion: CVAD-associated DVT resolution in children in the first 6 months since diagnosis was significantly lower if the thrombosis was occlusive, if it was located in the upper extremity, head, and neck veins; if collateral circulation was seen on ultrasound in the first 45 days; and/or when the patient showed less prothrombotic risk factors at diagnosis. What is Known: The risk factors associated with central venous access device-associated deep vein thrombosis resolution have been hardly evaluated in children. Current guidelines suggest anticoagulation for a maximum of 3 months in provoked vein thrombosis if the provoking factor is resolved. What is New: Thrombus resolution was lower if it was occlusive, located in the upper extremity veins, if collateral circulation was seen, and with less prothrombotic risk factors at diagnosis. To know if the thrombus will resolve after anticoagulation will help to choose whether to initiate and/or continue it or not.
引用
收藏
页码:1907 / 1914
页数:8
相关论文
共 28 条
  • [1] Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery
    Arlikar, Shilpa J.
    Atchison, Christie M.
    Amankwah, Ernest K.
    Ayala, Irmel A.
    Barrett, Laurie A.
    Branchford, Brian R.
    Streiff, Michael B.
    Takemoto, Clifford M.
    Goldenberg, Neil A.
    [J]. THROMBOSIS RESEARCH, 2015, 136 (04) : 717 - 722
  • [2] Development of venous thrombi in a pediatric population of intestinal failure
    Asouzu, Maurice A.
    Shroyer, Michelle
    Graham, John S.
    Wilkinson, Linda
    Galloway, David P.
    Martin, Colin A.
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2019, 54 (10) : 2145 - 2148
  • [3] Development of a New Risk Score for Hospital-Associated Venous Thromboembolism in Noncritically Ill Children: Findings from a Large Single-Institutional Case-Control Study
    Atchison, Christie M.
    Arlikar, Shilpa
    Amankwah, Ernest
    Ayala, Irmel
    Barrett, Laurie
    Branchford, Brian R.
    Streiff, Michael
    Takemoto, Clifford
    Goldenberg, Neil A.
    [J]. JOURNAL OF PEDIATRICS, 2014, 165 (04) : 793 - 798
  • [4] Postthrombotic syndrome and other outcomes of lower extremity deep vein thrombosis in children
    Avila, Maria Laura
    Pullenayegum, Eleanor
    Williams, Suzan
    Yue, Natasha
    Krol, Peter
    Brandao, Leonardo R.
    [J]. BLOOD, 2016, 128 (14) : 1862 - 1869
  • [5] A Clinical Tool for the Prediction of Venous Thromboembolism in Pediatric Trauma Patients
    Connelly, Christopher R.
    Laird, Amy
    Barton, Jeffrey S.
    Fischer, Peter E.
    Krishnaswami, Sanjay
    Schreiber, Martin A.
    Zonies, David H.
    Watters, Jennifer M.
    [J]. JAMA SURGERY, 2016, 151 (01) : 50 - 57
  • [6] Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolism
    Fan, Jennifer L.
    Roberts, Laura E.
    Scheurer, Michael E.
    Yee, Donald L.
    Shah, Mona D.
    Lee-Kim, YoungNa J.
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [7] Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (theKids-DOTT trial): pilot/feasibility phase findings
    Goldenberg, N. A.
    Abshire, T.
    Blatchford, P. J.
    Fenton, L. Z.
    Halperin, J. L.
    Hiatt, W. R.
    Kessler, C. M.
    Kittelson, J. M.
    Manco-Johnson, M. J.
    Spyropoulos, A. C.
    Steg, P. G.
    Stence, N. V.
    Turpie, A. G. G.
    Schulman, S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (09) : 1597 - 1605
  • [8] Gonzalez-Hernandez Jessica, 2016, J Pediatr Surg, V51, P790, DOI 10.1016/j.jpedsurg.2016.02.024
  • [9] Current approaches in the treatment of catheter-related deep venous thrombosis in children
    Jaffray, Julie
    Goldenberg, Neil
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (06) : 607 - 617
  • [10] A multi-institutional registry of pediatric hospital-acquired thrombosis cases: The Children's Hospital-Acquired Thrombosis (CHAT) project
    Jaffray, Julie
    Mahajerin, Arash
    Young, Guy
    Goldenberg, Neil
    Ji, Lingyun
    Sposto, Richard
    Stillings, Amy
    Krava, Emily
    Branchford, Brian
    [J]. THROMBOSIS RESEARCH, 2018, 161 : 67 - 72